ArticleTranslational vision science & technology2025
Longitudinal Simulated Driving Performance and Rates of Progressive Visual Field Loss in Glaucoma.
Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial Intelligence-Guided Endpoint Selection for Neuroprotection Trials in Glaucoma.American journal of ophthalmology · 2026Article
- Visual Impairment and Driving in Older Adults: A Narrative Review.Current treatment options in neurology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Purpose: The purpose of this study was to evaluate the association between longitudinal changes in driving performance, assessed through driving simulation, and rates of progressive visual field (VF) loss in patients with glaucoma. Methods: Ninety-five patients with glaucoma underwent Standard Automated Perimetry (SAP) and driving simulations every 6 months. Rates of VF loss were estimated by changes in mean sensitivity (MS) of the integrated binocular VF over time. Driving performance was assessed using a simulator by maintaining lane position on a winding road while responding to peripheral visual stimuli to assess divided attention. Reaction time (RT) recorded the duration between the presentation of the stimuli and the participant's response. Linear mixed models evaluated longitudinal changes in SAP MS and mean RT. Multivariable linear regression models were used to predict driving performance, adjusting for age, cognitive impairment, and driving exposure. Results: Progressive VF loss was associated with a longitudinal increase in mean RT to the divided attention task. In the multivariable model, each 1 decibel (dB)/year faster loss of integrated binocular MS was associated with a 0.024 logarithms (ln) s/year increase in mean RT (95% confidence interval [CI] = 0.007 to 0.042, P = 0.008). Baseline MS also significantly influenced driving performance, with each 10 dB worse baseline binocular MS associated with a 0.031 ln s/year increase in mean RT (95% CI = 0.016 to 0.045, P < 0.001). Conclusions: Faster VF progression in patients with glaucoma was associated with worsening performance on a divided attention task during driving simulation. Translational Relevance: Patients with glaucoma who exhibit faster VF progression may be at greater risk for a decline in driving performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.